Search research articles
Contact Us
Filters
Showing results (41-50 of 279) with videos related to
Page
of 28
Sort By:
Journal of the National Cancer Institute
|
April 9, 2009
Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker
Robert J Hamilton, Elizabeth A Platz, Stephen J Freedland
European Urology
|
August 21, 2019
Re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-9
Gregory J Nason, Michael A S Jewett, Robert J Hamilton
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 4, 2017
28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically
James R Hayes, Michael A S Jewett, Robert J Hamilton
Lancet (London, England)
|
June 1, 2025
Testicular cancer
Julian Chavarriaga, Lucia Nappi, Alexandros Papachristofilou, et al.
Prostate Cancer and Prostatic Diseases
|
June 29, 2022
Statins and prostate cancer-hype or hope? The biological perspective
Joseph Longo, Stephen J Freedland, Linda Z Penn, et al.
European Urology Focus
|
May 27, 2019
Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option
Robert J Hamilton, Michael A S Jewett, Padraig Warde, et al.
Annual Review of Medicine
|
November 6, 2013
Chemoprevention of prostate cancer
Goutham Vemana, Robert J Hamilton, Gerald L Andriole, et al.
JCO Oncology Practice
|
June 13, 2025
Optimal Management of Stage II Seminoma: Preventing Harm While Preserving Cure
Ciara Conduit, Aditya Bagrodia, Robert J Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2017
Challenges Interpreting Chemoprevention Studies Using Observational Data
Madhur Nayan, David N Juurlink, Antonio Finelli, et al.
Journal of the National Cancer Institute
|
October 30, 2008
The influence of statin medications on prostate-specific antigen levels
Robert J Hamilton, Kenneth C Goldberg, Elizabeth A Platz, et al.
Page
of 28
Search research articles
Search
Showing results (41-50 of 279) with videos related to
Sort By:
Page
of 28
Journal of the National Cancer Institute
|
April 9, 2009
Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker
Robert J Hamilton, Elizabeth A Platz, Stephen J Freedland
European Urology
|
August 21, 2019
Re: Adam C. Calaway, Lawrence H. Einhorn, Timothy A. Masterson, Richard S. Foster, Clint Cary. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer. Eur Urol 2019;76:607-9
Gregory J Nason, Michael A S Jewett, Robert J Hamilton
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
March 4, 2017
28-year late spermatic cord relapse of a testicular non-seminomatous germ cell tumour, managed robotically
James R Hayes, Michael A S Jewett, Robert J Hamilton
Lancet (London, England)
|
June 1, 2025
Testicular cancer
Julian Chavarriaga, Lucia Nappi, Alexandros Papachristofilou, et al.
Prostate Cancer and Prostatic Diseases
|
June 29, 2022
Statins and prostate cancer-hype or hope? The biological perspective
Joseph Longo, Stephen J Freedland, Linda Z Penn, et al.
European Urology Focus
|
May 27, 2019
Optimal Management of High-risk Stage I Nonseminomatous Germ Cell Tumor: Surveillance is the Preferred Option
Robert J Hamilton, Michael A S Jewett, Padraig Warde, et al.
Annual Review of Medicine
|
November 6, 2013
Chemoprevention of prostate cancer
Goutham Vemana, Robert J Hamilton, Gerald L Andriole, et al.
JCO Oncology Practice
|
June 13, 2025
Optimal Management of Stage II Seminoma: Preventing Harm While Preserving Cure
Ciara Conduit, Aditya Bagrodia, Robert J Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2017
Challenges Interpreting Chemoprevention Studies Using Observational Data
Madhur Nayan, David N Juurlink, Antonio Finelli, et al.
Journal of the National Cancer Institute
|
October 30, 2008
The influence of statin medications on prostate-specific antigen levels
Robert J Hamilton, Kenneth C Goldberg, Elizabeth A Platz, et al.
Page
of 28